Canaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $27

Benzinga Newsdesk www.benzinga.com Positive 58.5%

Neg 0% Neu 0% Pos 58.5%

Canaccord Genuity analyst Richard Close maintains HealthStream (NASDAQ:HSTM) with a Hold and raises the price target from $24 to $27.